Update from May 10th, 10:08 a.m.:
You have gained important experience by dealing with Astrazeneca.
The side effects are very rare, but must be taken very seriously.
Especially in the current phase, when almost all over 60-year-olds are vaccinated or have a vaccination appointment, the existing vaccination doses from Johnson & Johnson should be made accessible to everyone by lifting the vaccination prioritization, explains Spahn.
Update from May 10, 10:05 a.m.:
There are reports on cerebral vein thromboses from other countries about the corona vaccine from Johnson & Johnson, begins Spahn. Therefore, the federal and state health ministers have decided on this recommendation. The side effects are "to be taken seriously, but very rare". As with Astrazeneca, the prioritization is canceled. After medical advice, anyone can decide to be vaccinated with this vaccine.
First report from May 10th:
Berlin - The corona vaccine from Johnson & Johnson will generally be used in Germany for people over 60 in the future. After medical information, however, younger people can also decide, the federal and state health ministers decided, as the German press agency learned on Monday. The prioritization for this vaccine is canceled in medical practices and company doctors at the same time. This will be done from this Monday. Health Minister Jens Spahn commented on Monday.
As stated in the resolution of the Conference of Health Ministers, ministers take "the reported cases of cerebral vein thrombosis in connection with vaccination with the Johnson & Johnson vaccine" seriously. Similar to the Astrazeneca vaccine, such serious side effects were very rare.
Against this background, the Standing Vaccination Commission proposed the recommendation to vaccinate the preparation “for people aged> 60”. As with vaccinations with the Astrazeneca vaccine, vaccination should also be possible for under-60s after medical information and an individual risk analysis. The special thing about the vaccine from Johnson & Johnson is that, unlike the corona vaccines used to date, only one syringe is sufficient for full protection. (ph / dpa)